Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

8.54
Delayed Data
As of 9:30am ET
 +0.112 / +1.33%
Today’s Change
4.58
Today|||52-Week Range
13.50
+47.28%
Year-to-Date

Today’s Trading

Previous close8.43
Today’s open8.54
Day’s range8.54 - 8.57
Volume2,500
Average volume (3 months)65,281
Market cap$91.6M
Dividend yield--
Data as of 9:30am ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-125.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc+0.02+1.25%
EVARLombard Medical Inc0.000.00%
ITEKInotek Pharmaceutica...0.000.00%
CAPRCapricor Therapeutic...0.000.00%
Data as of 9:30am ET, 05/22/2015

Financials

Last reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$9.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers